- The Oxford–AstraZeneca COVID‑19 vaccine, sold
under the
brand names Covishield and
Vaxzevria among others, is a
viral vector vaccine for the prevention...
- not be
approved for the
general po****tion. For example, the CoronaVac,
Covishield, BBIBP-CorV and
Covaxin vaccines are not part of Australia's national...
-
March 2021, the
Government of
India temporarily froze exports of the
Covishield,
citing India's own
COVID crisis and the
domestic need for
these vaccines...
- (manufactured
under license by
Serum Institute of
India under the
trade name
Covishield) and
Covaxin (a
vaccine developed locally by
Bharat Biotech). They have...
-
contribution in
fighting Covid-19 by
successfully supplying huge
quantities of
Covishield in
India and globally, a
vaccine developed by Oxford-AstraZeneca and produced...
-
conditional use of AstraZeneca's COVID-19
vaccine AZD1222 (marketed as
Covishield).
Covishield is
developed by the
University of
Oxford and its spin-out company...
- M****
vaccination started on 26
March 2021,
initially with AstraZeneca's
Covishield vaccine. As of 7 June 2021,
Botswana has
administered 150,019 doses. In...
- from the
original on 15 May 2022.
Retrieved 18 May 2022. "5,000
doses of
Covishield/minute: A look at
Serum Institutes's
vaccine journey". Mint. 16 January...
-
conditional use of AstraZeneca's COVID-19
vaccine AZD1222 (marketed as
Covishield).
Covishield is
developed by the
University of
Oxford and its spin-out company...
-
conditional use of AstraZeneca’s COVID-19
vaccine AZD1222 (marketed as
Covishield).
Covishield is
developed by the
University of
Oxford and its spin-out company...
